Here's Why We're Not At All Concerned With Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn Situation
Mar 13
Polish (WIG) Healthcare Sector Analysis
UpdatedMar 21, 2023
DataAggregated Company Financials
Companies50
- 7D-1.4%
- 3M6.4%
- 1Y-7.9%
- YTD3.5%
Over the last 7 days, the Healthcare industry has dropped 1.3%, driven by Captor Therapeutics Spolka Akcyjna declining 12%. However, the industry is down 8.2% over the past year. Earnings are forecast to grow by 14% annually.
Sector Valuation and Performance
Has the Polish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 21 Mar 2023 | zł13.5b | zł15.1b | zł259.2m | 26.9x | 52x | 0.9x |
| Thu, 16 Feb 2023 | zł13.2b | zł15.0b | zł233.1m | 31.5x | 56.7x | 0.9x |
| Sat, 14 Jan 2023 | zł13.6b | zł15.0b | zł237.9m | 26.9x | 57.1x | 0.9x |
| Mon, 12 Dec 2022 | zł12.6b | zł15.0b | zł229.7m | 26.4x | 55x | 0.8x |
| Wed, 09 Nov 2022 | zł11.9b | zł14.8b | -zł136,902,320.00 | 19.5x | -87x | 0.8x |
| Fri, 07 Oct 2022 | zł11.9b | zł13.9b | -zł117,425,044.00 | 23.1x | -101.1x | 0.9x |
| Sun, 04 Sep 2022 | zł12.5b | zł15.0b | zł257.4m | 20.4x | 48.5x | 0.8x |
| Tue, 02 Aug 2022 | zł12.8b | zł14.8b | zł265.8m | 20.7x | 48.2x | 0.9x |
| Thu, 30 Jun 2022 | zł11.9b | zł14.8b | zł265.8m | 18.4x | 44.9x | 0.8x |
| Sat, 28 May 2022 | zł12.5b | zł14.7b | zł270.5m | 22.3x | 46.2x | 0.9x |
| Mon, 25 Apr 2022 | zł14.7b | zł15.1b | zł848.8m | 24.2x | 17.3x | 1x |
| Wed, 23 Mar 2022 | zł14.9b | zł14.9b | zł898.1m | 24.9x | 16.6x | 1x |
| Fri, 18 Feb 2022 | zł15.1b | zł14.8b | zł918.8m | 24.6x | 16.5x | 1x |
| Sun, 16 Jan 2022 | zł17.5b | zł14.8b | zł930.7m | 25.4x | 18.8x | 1.2x |
| Tue, 14 Dec 2021 | zł17.2b | zł14.8b | zł929.1m | 24.4x | 18.5x | 1.2x |
| Thu, 11 Nov 2021 | zł17.8b | zł14.7b | zł1.3b | 29.6x | 13.7x | 1.2x |
| Sat, 09 Oct 2021 | zł18.4b | zł14.7b | zł1.3b | 30.3x | 14.1x | 1.3x |
| Mon, 06 Sep 2021 | zł18.8b | zł14.6b | zł1.3b | 31.7x | 14x | 1.3x |
| Wed, 04 Aug 2021 | zł18.8b | zł14.4b | zł1.4b | 32.4x | 13.2x | 1.3x |
| Sat, 08 May 2021 | zł18.7b | zł14.0b | zł1.4b | 32.7x | 13.3x | 1.3x |
| Tue, 09 Feb 2021 | zł17.0b | zł13.8b | zł1.2b | 37.2x | 14.4x | 1.2x |
| Mon, 02 Nov 2020 | zł17.0b | zł12.8b | zł655.9m | 52.9x | 25.9x | 1.3x |
| Thu, 06 Aug 2020 | zł15.7b | zł11.9b | zł250.8m | 44x | 62.4x | 1.3x |
| Sun, 10 May 2020 | zł9.5b | zł11.7b | -zł103,109,076.00 | 47.7x | -91.8x | 0.8x |
Price to Earnings Ratio
-78.2x
Current Industry PE
- Investors are optimistic on the Polish Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 52.1x which is higher than its 3-year average PE of 9.2x.
- The 3-year average PS ratio of 1.1x is higher than the industry's current PS ratio of 0.89x.
Past Earnings Growth
- Total earnings for the Healthcare industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 8.9% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Trends
Which industries have driven the changes within the Polish Healthcare sector?
| PL Market | -2.77% | |
| Healthcare | -1.40% | |
| Life Sciences | 0.41% | |
| Healthcare Services | -0.97% | |
| Medical Equipment | -1.08% | |
| Healthtech | -2.96% | |
| Biotech | -3.24% | |
| Pharma | -3.40% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 26.6x.
- Analysts are expecting annual earnings growth of 13.8%, which is higher than its past year's earnings growth of 2.4% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 26% over the next 5 years.
- This is better than its past earnings growth rate of 14% per year.
- In contrast, the Biotech industry is expected to see its earnings decline by 44% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| RVU Ryvu Therapeutics | zł62.90 | 3.1% +zł43.9m | 38.2% | PS27.9x | |
| PTG Poltreg | zł53.00 | 6.0% +zł14.0m | 10.6% | PS206.1x | |
| BCX Bioceltix | zł43.50 | 9.6% +zł13.6m | 16.0% | n/a | |
| SDS SDS Optic Spolka Akcyjna | zł17.80 | 11.3% +zł10.4m | 68.7% | n/a | |
| EMC EMC Instytut Medyczny | zł9.50 | 2.2% +zł8.3m | -13.6% | PE212.8x |
